Mineralys Therapeutics, Inc. (MLYS) Q1 2025 Earnings Conference Call Transcript

Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q1 2025 Earnings Conference Call May 12, 2025 4:30 PM ET

Company Participants

Dan Ferry - LifeSci Advisors, IR

Jon Congleton - CEO

Dave Rodman - Chief Medical Officer

Adam Levy - CFO

Conference Call Participants

Michael DiFiore - Evercore ISI

Richard Law - Goldman Sachs

Seamus Fernandez - Guggenheim

Rami Katkhuda - LifeSci Capital

Operator

Good afternoon, ladies and gentlemen, and welcome to the Mineralys First Quarter 2025 Earnings Conference Call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct the question-and-answer session. [Operator Instructions] This call is being recorded on Monday, May 12, 2025.

I would now like to turn the conference over to Dan Ferry. Please go ahead.

Dan Ferry

Thank you, operator. We'd like to welcome everyone joining us today for our first quarter 2025 conference call. Earlier this afternoon, we issued a press release providing our first quarter 2025 financial results and business updates. A replay of today's call will be available on the Investors section of our website approximately 1 hour after its completion.

After our prepared remarks, we will open the call for Q&A.

Before we begin, I would like to remind everyone that this conference call and webcast will contain forward-looking statements about the company. Actual results could differ materially from those stated or implied by these forward-looking statements due to risks and uncertainties associated with the company's business. These forward-looking statements are qualified by the cautionary statements contained in today's press release and our SEC filings, including our annual report on Form 10-K and subsequent filings. Please note that these statements reflect our opinions only as of today, May 12, 2025, and as except as required by law, we specifically disclaim any obligation to update or revise these forward-looking statements in light of new information or future events.